Skip to main content

Table 1 Data for human post-mortem samples showing age at death, sex, post-mortem delay and pathological diagnosis

From: LMTK2 binds to kinesin light chains to mediate anterograde axonal transport of cdk5/p35 and LMTK2 levels are reduced in Alzheimer’s disease brains

Case Group

Autopsy Code

Sex

Age

Post-Mortem Delay (hrs)

Braak stage

Control

A002/13

M

90

45

Control

A007/15

F

74

64

II

Control

A033/11

M

82

47

I

Control

A046/12

F

92

9

II

Control

A048/09

M

82

18

Control

A063/10

F

90

50

II

Control

A082/14

M

68

60

II

Control

A105/14

F

77

21

Control

A158/14

F

73

27

I

Control

A209/13

M

80

55

II-III

Control

A213/12

M

78

24

III

Control

A308/09

M

66

52

Control

A319/14

F

90

44

II

Control

A346/10

F

84

34

I-II

Control

A407/13

F

80

22

II

AD Braak III-IV

A037/04

F

96

39

IV

AD Braak III-IV

A041/04

F

97

67.5

III-IV

AD Braak III-IV

A065/16

M

91

48

IV

A DBraak III-IV

A067/09

F

92

19.5

III

AD Braak III-IV

A078/13

M

86

52.5

IV

AD Braak III-IV

A084/16

F

86

55.5

IV

AD Braak III-IV

A097/13

M

82

28

IV

AD Braak III-IV

A101/08

F

92

29.5

IV

AD Braak III-IV

A189/07

F

83

41.5

IV

AD Braak III-IV

A223/12

F

83

22

IV

AD Braak III-IV

A232/16

F

95

47

IV

AD Braak III-IV

A282/11

M

93

13.5

IV

AD Braak III-IV

A374/14

M

88

79

III-IV

AD Braak III-IV

A378/14

M

98

53

IV

AD Braak III-IV

A381/16

M

84

86

IV

AD Braak VI

A008/12

M

66

41

VI

AD Braak VI

A064/16

F

93

49

VI

AD Braak VI

A087/16

F

89

38.5

VI

AD Braak VI

A100/15

F

73

30

VI

AD Braak VI

A105/13

F

81

17.5

VI

AD Braak VI

A166/12

F

86

25

VI

AD Braak VI

A171/14

M

84

67

VI

AD Braak VI

A226/16

F

69

73

VI

AD Braak VI

A258/16

M

67

39.5

VI

AD Braak VI

A289/13

M

83

22

VI

AD Braak VI

A331/15

M

86

38

VI

AD Braak VI

A342/14

F

84

27

VI

AD Braak VI

A355/14

F

79

31

VI

AD Braak VI

A377/14

F

85

79

VI

AD Braak VI

A380/13

F

81

20

VI

  1. AD Alzheimer’s disease, F female, M male